AU2005308534A1 - N- [ (3S)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors - Google Patents

N- [ (3S)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors Download PDF

Info

Publication number
AU2005308534A1
AU2005308534A1 AU2005308534A AU2005308534A AU2005308534A1 AU 2005308534 A1 AU2005308534 A1 AU 2005308534A1 AU 2005308534 A AU2005308534 A AU 2005308534A AU 2005308534 A AU2005308534 A AU 2005308534A AU 2005308534 A1 AU2005308534 A1 AU 2005308534A1
Authority
AU
Australia
Prior art keywords
pyrrolidin
benzamide
pain
compound
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005308534A
Other languages
English (en)
Inventor
Paul Vincent Fish
Thomas Ryckmans
Alan Stobie
Florian Wakenhut
Gavin Alistair Whitlock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU2005308534A1 publication Critical patent/AU2005308534A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AU2005308534A 2004-11-23 2005-11-18 N- [ (3S)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors Abandoned AU2005308534A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0425766.3 2004-11-23
GBGB0425766.3A GB0425766D0 (en) 2004-11-23 2004-11-23 Novel compounds
PCT/IB2005/003643 WO2006056884A1 (en) 2004-11-23 2005-11-18 N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors

Publications (1)

Publication Number Publication Date
AU2005308534A1 true AU2005308534A1 (en) 2006-06-01

Family

ID=33548739

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005308534A Abandoned AU2005308534A1 (en) 2004-11-23 2005-11-18 N- [ (3S)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors

Country Status (26)

Country Link
EP (1) EP1817281A1 (nl)
JP (1) JP4233596B2 (nl)
KR (1) KR100886294B1 (nl)
CN (1) CN101065355A (nl)
AP (1) AP2007004003A0 (nl)
AR (1) AR052243A1 (nl)
AU (1) AU2005308534A1 (nl)
BR (1) BRPI0518486A2 (nl)
CA (1) CA2589258A1 (nl)
CR (1) CR9171A (nl)
EA (1) EA011217B1 (nl)
GB (1) GB0425766D0 (nl)
GT (1) GT200500337A (nl)
IL (1) IL183191A0 (nl)
MA (1) MA29038B1 (nl)
MX (1) MX2007006138A (nl)
NL (2) NL1030485C2 (nl)
NO (1) NO20072486L (nl)
PA (1) PA8653501A1 (nl)
PE (1) PE20061056A1 (nl)
SV (1) SV2006002311A (nl)
TN (1) TNSN07201A1 (nl)
TW (1) TWI300776B (nl)
UY (1) UY29224A1 (nl)
WO (1) WO2006056884A1 (nl)
ZA (1) ZA200703910B (nl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH628885A5 (en) * 1978-01-01 1982-03-31 Anphar Sa Piperidine derivative
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
PT1638933E (pt) * 2003-06-17 2008-07-22 Pfizer Derivados de n-pirrolidin-3-il-amida como inibidores de recaptação de serotonina e noradrenalina

Also Published As

Publication number Publication date
PE20061056A1 (es) 2006-11-08
MA29038B1 (fr) 2007-11-01
TWI300776B (en) 2008-09-11
UY29224A1 (es) 2006-06-30
CR9171A (es) 2007-07-04
IL183191A0 (en) 2007-08-19
AR052243A1 (es) 2007-03-07
WO2006056884A1 (en) 2006-06-01
JP4233596B2 (ja) 2009-03-04
TW200626543A (en) 2006-08-01
NO20072486L (no) 2007-06-20
NL1030485C2 (nl) 2006-11-07
CA2589258A1 (en) 2006-06-01
SV2006002311A (es) 2006-09-14
JP2008520646A (ja) 2008-06-19
AP2007004003A0 (en) 2007-06-30
EP1817281A1 (en) 2007-08-15
GT200500337A (es) 2006-06-13
NL1032760C2 (nl) 2007-04-17
CN101065355A (zh) 2007-10-31
EA200700920A1 (ru) 2007-12-28
BRPI0518486A2 (pt) 2008-11-18
TNSN07201A1 (fr) 2008-11-21
MX2007006138A (es) 2007-07-19
NL1030485A1 (nl) 2006-05-24
EA011217B1 (ru) 2009-02-27
NL1032760A1 (nl) 2006-12-13
KR20070086599A (ko) 2007-08-27
ZA200703910B (en) 2008-09-25
PA8653501A1 (es) 2006-06-02
KR100886294B1 (ko) 2009-03-04
GB0425766D0 (en) 2004-12-22

Similar Documents

Publication Publication Date Title
US7122683B2 (en) Amides useful as monoamine re-uptake inhibitors
JP6463580B2 (ja) ナトリウムチャネルの調節剤として有用なピリドンアミドのプロドラッグ
AU2014212431B2 (en) Amides as modulators of sodium channels
CN104136442B (zh) 作为离子通道调节剂的吡喃‑螺环哌啶酰胺类
WO2014120815A1 (en) Quinoline and quinazoline amides as modulators of sodium channels
WO2011016234A1 (en) Picolinamide derivatives as ttx-s blockers
AU2005266090A1 (en) Pyridine derivatives
WO2007125398A2 (en) : sulfonamide compounds as antagonists of the n-type calcium channel
JP4157158B2 (ja) ドーパミン作動薬の新規な塩の形態
WO2007057775A1 (en) Spiropiperidine derivatives
CA2591415A1 (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
US20090239928A1 (en) N-Pyrrolidin-3YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors
US20090239929A1 (en) N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors
NL1032760C2 (nl) Nieuwe verbindingen.
WO2007135530A2 (en) Pharmaceutically & veterinarily suitable salt

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application